Greg Mattingly, MD, Associate Clinical Professor, Washington University, St. Louis, Missouri, discusses needs that remain unmet in the treatment of depression.
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
In this video, Michael J. Bloch, MD, provides a preview of the virtual anticoagulation sessions at CHEST 2021, including an update on COVID-19 and venous thromboembolic disease challenges and clinical...
In this video, Antonio Anzueto, MD, talks about the next steps in his research into treatment options for patients with symptomatic COPD who are at high risk of exacerbations.
